HPV vaccine and Gardasil 9 in NYC

FDA labeling covers ages 9–45. CDC recommends routine vaccination at 11–12, starting as early as 9, and catch-up through 26. Ages 27–45 use shared clinical decision making rather than a universal recommendation. Most people starting before 15 need two doses; those starting at 15 or older and immunocompromised people need three.

Gardasil 9 is FDA-approved through age 45. CDC uses shared clinical decision making at ages 27–45 because benefit varies with prior exposure and future risk. It is not a universal catch-up recommendation for this whole age group. Vaccination does not treat an existing HPV infection.

Starting before the 15th birthday usually means two doses 6–12 months apart; doses less than five months apart need a third. Starting at 15 or older usually means three doses at 0, 1–2, and 6 months. Immunocompromised people need three doses even if starting at 9–14. Valid late doses generally continue without restarting.

No. HPV testing is not required to decide whether an otherwise eligible person can be vaccinated. The vaccine prevents new infections and does not treat an existing HPV infection or abnormal screening result. Continue the screening appropriate to your age and history.

HPV vaccination is deferred during pregnancy. If a dose was given before pregnancy was recognized, the remaining doses are delayed until afterward; this is not a reason to restart. Severe yeast or prior-dose allergy requires review. Sit or lie down during administration and remain for the advised observation period because fainting can occur.

No. Continue recommended cervical cancer screening even after HPV vaccination. The vaccine does not treat an existing infection and does not cover every cancer-causing HPV type. A previous abnormal result needs its own follow-up.

Several indicated vaccines can often be given at one visit. The clinician checks age, prior reactions, immune status, and the product schedules. Live injectable vaccines such as MMR and varicella generally need the same day or at least 28 days between them. A convenient appointment does not override minimum ages or intervals.

Contact the selected clinic before traveling and name hpv vaccination and gardasil, the recipient’s age, and any date or brand requirement. Ask whether it has the correct product and can administer it for this indication. A general walk-in or appointment slot does not reserve a dose or establish coverage.

HPV vaccine prevents new infections; it does not treat an existing infection or abnormal screening result. CDC does not recommend an additional Gardasil 9 series after a correctly completed earlier HPV series. Bring records to confirm completion, and follow the clinician’s screening or treatment plan for persistent HPV. Shared decision making at ages 27–45 is not a routine revaccination rule.

Many adults have already encountered HPV, so the average additional benefit is smaller. Vaccination prevents new infections and does not treat existing HPV. CDC recommends catch-up through 26; inadequately vaccinated adults 27–45 can discuss whether they would benefit. This is shared clinical decision-making, not a rule that nobody over 26 may receive it.

The original Gardasil received U.S. licensure in 2006; Gardasil 9 was first approved on December 10, 2014. These are different formulations. Today’s vaccine choice and number of doses follow age at series start, immune status and valid previous records, rather than the year the first HPV vaccine appeared.